Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Optimizing these processes involves fine-tuning various factors, including cell line engineering, media formulation, and bioreactor environments. A key goal is to amplify antibody production while reducing productio